000			04179cam a2200517Ii 4500
001			ocn912875316
003			OCoLC
005			20240729131908.0
006			m d
007			cr cnu|||unuuu
008			150702t20152015nyua ob 001 0 eng d
040			_aN$T _beng _erda _epn _cN$T _dN$T _dEBLCP _dYDXCP _dOCLCQ
019			_a918623639
020			_a9781634825832 _q(electronic bk.)
020			_a1634825837 _q(electronic bk.)
020			_z9781634825528
035			_a(OCoLC)912875316 _z(OCoLC)918623639
072		7	_aMED _x033000 _2bisacsh
049			_aMAIN
245	0	0	_aMenorrhagia and dysmenorrhea : _brisk factors, diagnosis and management _c _h[E-Book]
264		1	_aNew York : _bNova Science Publishers, Inc., _c[2015]
300			_a1 online resource.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
490	1		_aObstetrics and gynecology advances
504			_aIncludes bibliographical references (pages 76-83) and index.
588	0		_aVendor-supplied metadata.
505	0		_aMENORRHAGIA AND DYSMENORRHEA: RISK FACTORS, DIAGNOSIS AND MANAGEMENT; MENORRHAGIA AND DYSMENORRHEA: RISK FACTORS, DIAGNOSIS AND MANAGEMENT; Library of Congress Cataloging-in-Publication Data; Contents; Preface; Chapter I: Menorrhagia: Risk Factors, Diagnosis and Treatment; Abstract; Introduction; Definition of Menorrhagia and Its Epidemiology; Anamnestic Features of Menorrhagia; Examination; Investigation; Imaging; Management; Medical Management of Heavy Menstrual Loss in the Acute and Long-Term; Conclusion; References; Chapter II: Management of Heavy Menstrual Bleeding; Abstract.
505	8		_a1. Introduction2. Medical Treatment; Combined Oral Contraceptive Pills (COCPs); Oral Progesterone; Levonorgestrel Intrauterine System (LNG-IUS); 3. Surgical Management; Endometrial Ablation; Uterine Artery Embolization (UAE); Hysterectomy; 4. Duration of Therapy Preferences; Conclusion; References; Chapter III: The Role of Endometrial Inflammation in the Pathogenesis of Menorrhagia and the Clinical Use of NF-Kappa.b Natural Inhibitors with Hormone Therapy; Overview: Menstruation, Inflammation and the Role of Progesterone.
505	8		_aThe Role of Inflammation and Local Estrogen Production in the Etiology of MenorrhagiaThe Association of Natural NF-Kappa.b Inhibitors with Oral Contraceptives in the Treatment of Menorrhagia; Hormonal Treatment of Menorrhagia and Dysmenorrhea with Vaginal Gestrinone Associated with Natural NF-Kappa.b Inhibitors; References; Chapter IV: Management of Dysmenorrhea in Women with Endometriosis; Abstract; Introduction; Epidemiology of Dysmenorrhea in Women with Endometriosis; Pathogenesis of Dysmenorrhea in Women with Endometriosis; Treatment of Dysmenorrhea; Hormonal Treatment.
505	8		_aNon-Steroidal Anti-Inflammatory DrugsProgestins; Danazol; Combined Oral Contraceptives; Gonadotrophin Releasing Hormone Analogues; Gonadotrophin Releasing Hormone Antagonist; Aromatase Inhibitors; Surgical Treatment; Conclusion; References; Index.
520			_aMenorrhagia is defined as heavy menstrual loss. Its main determinant of management is the impact of menorrhagia on the woman's quality of life. This book examines the history of menorrhagia, which should elucidate the temporal aspects of the heavy menstrual blood loss and may shed light on the etiology of menorrhagia. The authors further provide instructions on how to examine and treat women with menorrhagia. Furthermore, the book outlines a diagnostic approach and concentrates on different therapies like combined oral contraceptive pills in contrast with surgical management. With an effective.
650		0	_aMenorrhagia _xTreatment.
650		0	_aMenorrhagia _xDiagnosis.
650		0	_aDysmenorrhea _xTreatment.
650		0	_aDysmenorrhea _xDiagnosis.
700	1		_aWelch, Timothy M., _eeditor.
830		0	_aObstetrics and gynecology advances.
856			_u#gotoholdings _yAccess resource
938			_aEBL - Ebook Library _bEBLB _nEBL2130684
938			_aEBSCOhost _bEBSC _n1020627
938			_aYBP Library Services _bYANK _n12375601
942			_n0
994			_a92 _bN$T
999			_c92220 _d92220